Frequent Promoter Hypermethylation of the APC and RASSF1A Tumour Suppressors in Parathyroid Tumours
Open Access
- 1 March 2010
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 5 (3) , e9472
Abstract
Parathyroid adenomas constitute the most common entity in primary hyperparathyroidism, and although recent advances have been made regarding the underlying genetic cause of these lesions, very little data on epigenetic alterations in this tumour type exists. In this study, we have determined the levels of promoter methylation regarding the four tumour suppressor genes APC, RASSF1A, p16INK4A and RAR-β in parathyroid adenomas. In addition, the levels of global methylation were assessed by analyzing LINE-1 repeats. The sample collection consisted of 55 parathyroid tumours with known HRPT2 and/or MEN1 genotypes. Using Pyrosequencing analysis, we demonstrate APC promoter 1A and RASSF1A promoter hypermethylation in the majority of parathyroid tumours (71% and 98%, respectively). Using TaqMan qRT-PCR, all tumours analyzed displayed lower RASSF1A mRNA expression and higher levels of total APC mRNA than normal parathyroid, the latter of which was largely conferred by augmented APC 1B transcription levels. Hypermethylation of p16INK4A was demonstrated in a single adenoma, whereas RAR-β hypermethylation was not observed in any sample. Moreover, based on LINE-1 analyses, parathyroid tumours exhibited global methylation levels within the range of non-neoplastic parathyroid tissues. The results demonstrate that APC and RASSF1A promoter hypermethylation are common events in parathyroid tumours. While RASSF1A mRNA levels were found downregulated in all tumours investigated, APC gene expression was retained through APC 1B mRNA levels. These findings suggest the involvement of the Ras signaling pathway in parathyroid tumorigenesis. Additionally, in contrast to most other human cancers, parathyroid tumours were not characterized by global hypomethylation, as parathyroid tumours exhibited LINE-1 methylation levels similar to that of normal parathyroid tissues.Keywords
This publication has 45 references indexed in Scilit:
- A Cohort Study of Tumoral LINE-1 Hypomethylation and Prognosis in Colon CancerJNCI: Journal of the National Cancer Institute, 2008
- The parafibromin tumor suppressor protein inhibits cell proliferation by repression of the c-myc proto-oncogeneProceedings of the National Academy of Sciences, 2008
- Aberrant methylation of the Adenomatous Polyposis Coli (APC) gene promoter is associated with the inflammatory breast cancer phenotypeBritish Journal of Cancer, 2008
- Genetic Changes of Wnt Pathway Genes Are Common Events in Metaplastic Carcinomas of the BreastClinical Cancer Research, 2008
- Profiling CpG island field methylation in both morphologically normal and neoplastic human colonic mucosaBritish Journal of Cancer, 2008
- Molecular analysis of APC promoter methylation and protein expression in colorectal cancer metastasisCarcinogenesis, 2005
- QuantitativeRARβ2HypermethylationClinical Cancer Research, 2004
- HRPT2, encoding parafibromin, is mutated in hyperparathyroidism–jaw tumor syndromeNature Genetics, 2002
- The RASSF1A Tumor Suppressor Blocks Cell Cycle Progression and Inhibits Cyclin D1 AccumulationMolecular and Cellular Biology, 2002
- Construction of a 1.2-Mb Sequence-Ready Contig of Chromosome 11q13 Encompassing the Multiple Endocrine Neoplasia Type 1 (MEN1) GeneGenomics, 1997